Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20+, B-cell Lymphomas”

315 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 315 results

Very early researchStudy completedNCT02144623
What this trial is testing

Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Lund University Hospital 4
Large-scale testing (Phase 3)Ended earlyNCT01287741
What this trial is testing

Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 1,418
Large-scale testing (Phase 3)Ended earlyNCT01659099
What this trial is testing

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma CD20 Positive
The Lymphoma Academic Research Organisation 671
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Large-scale testing (Phase 3)Study completedNCT00003595
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 120
Early research (Phase 1)Ended earlyNCT02483000
What this trial is testing

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Who this might be right for
Burkitt LymphomaCD20-Positive Neoplastic Cells PresentDiffuse Large B-Cell Lymphoma+4 more
Fred Hutchinson Cancer Center 3
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Looking for participantsNCT06395870
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentB-Cell Non-Hodgkin Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital 33
Early research (Phase 1)Study completedNCT04655677
What this trial is testing

C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886139
What this trial is testing

TRS005 in Patients With CD20-positive R/R DLBCL.

Who this might be right for
CD20-positive Diffuse Large B-Cell Lymphoma
Zhejiang Teruisi Pharmaceutical Inc. 139
Very early researchTemporarily pausedNCT04697290
What this trial is testing

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Beijing Tsinghua Chang Gung Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01363128
What this trial is testing

Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete RemissionBurkitt Leukemia+4 more
M.D. Anderson Cancer Center 72
Large-scale testing (Phase 3)Study completedNCT01459887
What this trial is testing

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Shanghai CP Guojian Pharmaceutical Co., Ltd. 278
Testing effectiveness (Phase 2)Ended earlyNCT02495454
What this trial is testing

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20 Positive Diffuse Large B-cell LymphomaElderly Unfit Patients
Fondazione Italiana Linfomi - ETS 34
Early research (Phase 1)Ended earlyNCT00033423
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 18
Testing effectiveness (Phase 2)Ended earlyNCT02151903
What this trial is testing

Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Alopexx Oncology, LLC 5
Early research (Phase 1)UnknownNCT03576807
What this trial is testing

The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphomas
Xin Wang 20
Testing effectiveness (Phase 2)Looking for participantsNCT06088654
What this trial is testing

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Innate Pharma 184
Early research (Phase 1)Study completedNCT03019666
What this trial is testing

Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more
Masonic Cancer Center, University of Minnesota 39
Load More Results